UK Markets closed

BBS-Bioactive Bone Substitutes Oyj (BONEH.HE)

Helsinki - Helsinki Real-time price. Currency in EUR
Add to watchlist
2.4400-0.0500 (-2.01%)
At close: 06:18PM EET
Full screen
Previous close2.2500
Open2.2600
Bid2.2300 x N/A
Ask2.2700 x N/A
Day's range2.2500 - 2.2800
52-week range1.6200 - 4.0200
Volume3,130
Avg. volume19,471
Market cap16.44M
Beta (5Y monthly)-0.56
PE ratio (TTM)N/A
EPS (TTM)-0.3980
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Globe Newswire

    BBS-Bioactive Bone Substitutes Plc: US Patent for the Manufacture of ARTEBONE® product

    BBS-Bioactive Bone Substitutes Plc, Company announcement, inside information, 11th January 2022 at 14:00 EET BBS-Bioactive Bone Substitutes Plc: US Patent for the Manufacture of ARTEBONE® product As announced in November 17 2021 release “A METHOD FOR PREPARING A BONE PROTEIN PREPARATION AND A BONE PROTEIN PREPARATION”, after the approval of the patent application for manufacturing claims of BBS-Bioactive Bone Substitutes Plc's (“Company”), this patent has now been granted in the United States on

  • Globe Newswire

    BBS-Bioactive Bone Substitutes Plc: Financial calendar and Annual General Meeting in 2022

    BBS-Bioactive Bone Substitutes, Company announcement, 10th December 2021 at 9:40 a.m. BBS-Bioactive Bone Substitutes Plc: Financial calendar and Annual General Meeting in 2022 During the year 2022, BBS-Bioactive Bone Substitutes Plc (”BBS”) will publish the financial information as follows: Financial Statements Release for the year 2021 Thursday, 24 February 2022Half-year financial report January-June 2022 Thursday, 25 August 2022The Annual Report for the year 2021 will be published during the w

  • Globe Newswire

    BBS-Bioactive Bone Substitutes Plc: Conversion of convertible notes pursuant to financing arrangement between BBS-Bioactive Bone Substitutes Plc ja Riverfort Global Opportunities PCC Ltd

    BBS-Bioactive Bone Substitutes Plc, Company announcement, 19th November 2021 14:30 pm BBS-Bioactive Bone Substitutes Plc: Conversion of convertible notes pursuant to financing arrangement between BBS-Bioactive Bone Substitutes Plc ja Riverfort Global Opportunities PCC Ltd The Board of Directors of BBS Bioactive Bone Substitutes Plc (the "Company") has, pursuant to the terms and conditions of the financing arrangement between the Company and Riverfort Global Opportunities PCC Ltd announced on Sep